Intellia Therapeutics, Inc.

Historical 13F Holders

Symbol
NTLA
CUSIP
45826J105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 45826J105 since 12/18/2024, largest first.

Filer % of Class Filed
ARK Investment Management LLC 13G/A
12.3% 2/3/2026
Event 12/31/2025
BlackRock, Inc. 13G/A 8.2% 4/17/2025
Event 3/31/2025
State Street Corp 13G 6.8% 8/7/2026
Event 6/30/2026
Vanguard Portfolio Management LLC 13G 5.3% 4/29/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.0% 4/30/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Goldman Sachs Group Inc 13G/A
2.7% 2/12/2026
Event 12/31/2025
Contrarius Investment Management Ltd 13G/A
0.6% 2/11/2026
Event 12/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 6 9.12 k $110 k
2026 Q2 358 147 M $2.59 B
2026 Q1 326 111 M $1.42 B
2025 Q4 327 104 M $939 M
2025 Q3 318 105 M $1.81 B
2025 Q2 309 101 M $948 M
2025 Q1 320 101 M $722 M
2024 Q4 314 99.3 M $1.16 B
2024 Q3 302 93.9 M $1.93 B
2024 Q2 315 93.1 M $2.08 B
2024 Q1 309 97.1 M $2.67 B
2023 Q4 316 89.3 M $2.72 B
2023 Q3 311 80.3 M $2.54 B
2023 Q2 311 78.3 M $3.19 B
2023 Q1 313 78.9 M $2.94 B
2022 Q4 328 81.9 M $2.86 B
2022 Q3 352 68.2 M $3.82 B
2022 Q2 326 67.7 M $3.45 B
2022 Q1 380 65.4 M $4.73 B
2021 Q4 401 64.4 M $7.62 B
2021 Q3 387 62.2 M $8.34 B
2021 Q2 381 62.4 M $10.1 B
2021 Q1 290 63.2 M $5.07 B
2020 Q4 262 62.9 M $3.44 B
2020 Q3 177 56.5 M $1.13 B
2020 Q2 173 53.9 M $1.13 B
2020 Q1 153 53.6 M $656 M
2019 Q4 158 46.2 M $677 M
2019 Q3 145 44.1 M $589 M
2019 Q2 159 39.0 M $639 M
2019 Q1 160 34.0 M $582 M
2018 Q4 151 31.9 M $435 M
2018 Q3 171 29.6 M $847 M
2018 Q2 170 29.2 M $798 M
2018 Q1 142 26.8 M $565 M
2017 Q4 124 24.6 M $474 M
2017 Q3 93 18.0 M $447 M
2017 Q2 90 16.8 M $269 M
2017 Q1 79 17.0 M $239 M
2016 Q4 71 18.6 M $244 M
2016 Q3 65 14.3 M $243 M
2016 Q2 63 14.2 M $302 M
2016 Q1 1 215 $4.00 k